First Time Loading...

Surmodics Inc
NASDAQ:SRDX

Watchlist Manager
Surmodics Inc Logo
Surmodics Inc
NASDAQ:SRDX
Watchlist
Price: 32.49 USD -5.96% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one SRDX stock under the Base Case scenario is 41.62 USD. Compared to the current market price of 32.49 USD, Surmodics Inc is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SRDX Relative Value
Base Case
41.62 USD
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
79
vs Industry
36
Median 3Y
4.7
Median 5Y
5.5
Industry
2.4
Forward
3.8
More Details
83.7
P/E
P/E
Price to Earnings
83.7
vs History
34
vs Industry
5
Median 3Y
-8.9
Median 5Y
77.8
Industry
23.4
Forward
-33.8
More Details
36.9
P/OCF
P/OCF
Price to OCF
36.9
vs History
46
vs Industry
10
Median 3Y
36.5
Median 5Y
39
Industry
15.5
More Details
56.7
P/FCFE
P/FCFE
Price to FCFE
56.7
vs History
30
vs Industry
10
Median 3Y
15.6
Median 5Y
36.6
Industry
23.2
More Details
3.8
P/B
P/B
Price to Book Value
3.8
vs History
65
vs Industry
23
Median 3Y
4.1
Median 5Y
4.4
Industry
2.3
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
77
vs Industry
34
Median 3Y
4.7
Median 5Y
5
Industry
2.5
Forward
3.7
More Details
4.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.2
vs History
77
vs Industry
50
Median 3Y
5.9
Median 5Y
5.9
Industry
5.3
More Details
22
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22
vs History
63
vs Industry
15
Median 3Y
23.4
Median 5Y
34.1
Industry
12.6
Forward
105.9
More Details
37.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
37.9
vs History
53
vs Industry
10
Median 3Y
40.3
Median 5Y
63.1
Industry
17.2
Forward
-35.5
More Details
36.5
EV/OCF
EV/OCF
Enterprise Value to OCF
36.5
vs History
44
vs Industry
10
Median 3Y
36
Median 5Y
37.2
Industry
15.3
More Details
46.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
46.3
vs History
44
vs Industry
10
Median 3Y
45.7
Median 5Y
45.7
Industry
19.8
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
66
vs Industry
25
Median 3Y
3.4
Median 5Y
4.1
Industry
2
More Details

Multiples Across Competitors

SRDX Competitors Multiples
Surmodics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Surmodics Inc
NASDAQ:SRDX
462.5m USD 3.3 83.7 22 37.9
US
Abbott Laboratories
NYSE:ABT
183.6B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.3B USD 18.5 68.1 55.8 70
US
Stryker Corp
NYSE:SYK
125.1B USD 6 37.2 24.2 29.7
IE
Medtronic PLC
NYSE:MDT
108.6B USD 3.4 25.9 13.8 19.5
US
Boston Scientific Corp
NYSE:BSX
106.8B USD 7.3 60.5 30.8 45.5
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD 3.5 55.6 18.6 39.4
DE
Siemens Healthineers AG
XETRA:SHL
57.9B EUR 2.7 38.1 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.3B USD 8.4 36.3 26.4 28.5
US
Dexcom Inc
NASDAQ:DXCM
50.8B USD 13.4 79.5 59.5 77.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3

See Also

Summary
SRDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
SRDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SRDX stock valuation using valuation multiples.
Wall Street Estimates
SRDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SRDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.